Frontier Scientific Solutions (Frontier) and Air Transport Services Group, Inc. (ATSG) have teamed up to change the way temperature-sensitive pharmaceuticals are shipped worldwide. The partnership sets up a dedicated air corridor for life sciences, designed to keep shipments within precise temperature ranges and ensure they reach their destinations safely.
Frontier, which handles logistics exclusively for the life sciences sector, and ATSG, a leading air cargo provider, will operate a purpose-built air logistics network together. The system is designed to meet the demanding regulatory, operational, and security needs of pharmaceutical, biotechnology, and medical device companies.The air network for pharma is designed to meet the tough regulatory, operational, and security standards of the pharmaceutical, biotechnology, and medical device industries. The initiative builds on Frontier’s existing $1.5 billion commitment from GID, earmarked for infrastructure and network expansion, establishing a high-integrity logistics platform to serve major life science markets worldwide.
“The launch of our air network represents a major milestone in enhancing connected global infrastructure for life sciences,” said Steve Uebele, Chief Executive Officer of Frontier. “By linking Europe and the United States with additional strategic hubs under development, we are creating a logistics backbone that minimizes handoffs, maintains temperature control, and delivers total visibility and compliance across every stage of the journey.”
The partnership introduces a dedicated fleet of temperature-controlled aircraft and globally validated routes connecting key life science hubs. This infrastructure sets a new benchmark for precision and reliability in cold-corridor logistics.
“This partnership reflects how ATSG leverages its air cargo expertise to deliver exceptional value to our partners,” said Greg Mays, President of ATSG. “Transforming how an industry moves and protects critical products is at the heart of what we do. By applying more than 40 years of experience and leadership in time-sensitive networks, we’ve created a dedicated solution designed to meet the complex, highly regulated demands of the life sciences sector.”
Frontier’s model is structured to reduce the usual 20 or more handoffs found in traditional pharmaceutical supply chains to fewer than four. Its network, facilities, and processes are operated exclusively for life sciences, staffed with teams experienced in the sector and following SOPs calibrated for zero-loss, zero-excursion performance. With cGDP-validated ground facilities, dedicated air transport, and centralized quality oversight, Frontier is setting a new standard for life science logistics around the world.
Frontier’s North American operations are anchored at its Wilmington, North Carolina air gateway, while Shannon, Ireland, serves as its European, Middle Eastern, and African hub. The company plans further expansion through 2026, adding hubs to support major life science manufacturing and distribution markets.
The dedicated air network for pharma will allow Frontier to establish secure, compliant cold corridors worldwide, meeting growing demand for biologics, GLP-1 therapies, and other temperature-sensitive treatments critical to patient care.
